UPDATE : US FDA Warning Letter related to excipients produced by DuPont at 1301 Ogletown Rd, Newark, DE 19711, United States.
Further to our notice of 10 January 2023, as the investigation surrounding this regulatory action continues, the EXCiPACT certificate for this site has been suspended for a period of six months, in accordance with the requirements of the EXCiPACT standard (9.6.5 Suspending, withdrawing or reducing the scope of certification).
The situation will be closely monitored. Within EXCiPACT itself, appropriate corrective and preventive actions will be identified and implemented in response to this event.
EXCiPACT will continue to provide updates though this website. EXCiPACT can be contacted at email@example.com or +32 (0)2 213 74 49.